| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | NEUTRAL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 45.68▲ | 45.81▲ | 46.07▲ | 46.18▲ | 47.10▲ |
| MA10 | 46.06▲ | 46.43▲ | 46.61▲ | 46.43▲ | 48.12▼ |
| MA20 | 46.96▲ | 47.28▲ | 47.60▼ | 47.16▲ | 46.77▲ |
| MA50 | 48.53▼ | 48.49▼ | 48.47▼ | 48.42▼ | 44.75▲ |
| MA100 | 47.76▼ | 47.48▼ | 47.27▲ | 46.56▲ | 40.93▲ |
| MA200 | 46.27▲ | 45.93▲ | 45.69▲ | 45.25▲ | 38.52▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.019▲ | -0.065▼ | -0.124▼ | 0.029▲ | -0.296▼ |
| RSI | 51.259▲ | 49.367▼ | 48.309▼ | 49.885▼ | 53.480▲ |
| STOCH | 28.103 | 27.105 | 35.545 | 48.617 | 39.875 |
| WILL %R | -14.959▲ | -26.130 | -35.591 | -16.719▲ | -53.836 |
| CCI | 73.313 | 50.020 | 14.889 | 56.065 | -30.247 |
|
Tuesday, July 28, 2026 05:22 AM
Altimmune Inc. (NASDAQ:ALT) shares climbed 18% on Tuesday after the biotechnology company reported positive topline data from its Phase 2 RECLAIM study evaluating pemvidutide as a treatment for ...
|
|
Thursday, June 04, 2026 05:49 AM
Track conference calls, annual meetings, summits, analyst days and other corporate events scheduled for Altimmune Inc. Use the full market events calendar to scan activity across all tickers.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/08/26 | 47.11 | 47.3291 | 46.73 | 47.3291 | 5,740 |
| 03/08/26 | 46.83 | 47.1907 | 46.79 | 47.1907 | 38,102 |
| 31/07/26 | 46.09 | 46.31 | 46.05 | 46.06 | 2,193 |
| 30/07/26 | 45.76 | 46.0731 | 45.54 | 46.0417 | 2,057 |
| 29/07/26 | 45.23 | 45.57 | 44.2861 | 44.2861 | 6,579 |
| 28/07/26 | 45.09 | 45.77 | 45.02 | 45.77 | 5,216 |
| 27/07/26 | 46.96 | 46.96 | 45.84 | 46.4662 | 4,570 |
| 24/07/26 | 46.91 | 47.14 | 46.4126 | 46.4126 | 6,197 |
| 23/07/26 | 47.06 | 47.67 | 47.06 | 47.1534 | 737 |
| 22/07/26 | 47.34 | 47.94 | 47.34 | 47.64 | 2,914 |
|
|
||||
|
|
||||
|
|